iDAP Injection in the Treatment of Parkinson's Disease

NCT06583291 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

OTHER_GOV

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Allogeneic dopaminergic neural precursor cell(iDAP)

Sponsor

Anhui Provincial Hospital